MS drug may cause liver injury

The immunotherapy drug alemtuzumab (Lemtrada) for multiple sclerosis may induce liver injury, gastroenterologists in Melbourne say. The monoclonal antibody used in relapsing and remitting multiple sclerosis (RRMS) has not previously been associated with drug induced liver injury, but Dr William Beattie and colleagues at the Royal Melbourne hospital report a likely case in a 49 year ...

Already a member?

Login to keep reading.

© 2021 the limbic